title: Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia.
abstract: BACKGROUND
  Rare chronic diseases of childhood are often complex and associated with multiple health issues. Such conditions present significant demands on health services, but the degree of these demands is seldom reported. This study details the utilisation of hospital services and associated costs in a single case of surfactant protein C deficiency, an example of childhood interstitial lung disease.
  
  
  METHODS
  Hospital records and case notes for a single patient were reviewed. Costs associated with inpatient services were extracted from a paediatric hospital database. Actual costs were compared to cost estimates based on both disease/procedure-related cost averages for inpatient hospital episodes and a recently implemented Australian hospital funding algorithm (activity-based funding).
  
  
  RESULTS
  To age 8 years and 10 months the child was a hospital inpatient for 443 days over 32 admissions. A total of 298 days were spent in paediatric intensive care. Investigations included 58 chest x-rays, 9 bronchoscopies, 10 lung function tests and 11 sleep studies. Comprehensive disease management failed to prevent respiratory decline and a lung transplant was required. Costs of inpatient care at three tertiary hospitals totalled $966,531 (Australian dollars). Disease- and procedure-related cost averages underestimated costs of paediatric inpatient services for this patient by 68%. An activity-based funding algorithm that is currently being adopted in Australia estimated the cost of hospital health service provision with more accuracy.
  
  
  CONCLUSIONS
  Health service usage and inpatient costs for this case of rare chronic childhood respiratory disease were substantial. This case study demonstrates that disease- and procedure-related cost averages are insufficient to estimate costs associated with rare chronic diseases that require complex management. This indicates that the health service use for similar episodes of hospital care is greater for children with rare diseases than other children. The impacts of rare chronic childhood diseases should be considered when planning resources for paediatric health services.
authors.forename: Neil J
authors.initials: NJ
authors.lastname: Hime
authors.forename: Dominic
authors.initials: D
authors.lastname: Fitzgerald
authors.forename: Paul
authors.initials: P
authors.lastname: Robinson
authors.forename: Hiran
authors.initials: H
authors.lastname: Selvadurai
authors.forename: Peter
authors.initials: P
authors.lastname: Van Asperen
authors.forename: Adam
authors.initials: A
authors.lastname: Jaffé
authors.affiliation: Australian Paediatric Surveillance Unit, Kids Research Institute, Westmead, NSW 2145, Australia. yvonne.zurynski@health.nsw.gov.au.
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Zurynski
mesh_terms: D000465:Algorithms; D001315:Australia; D017281:Cost of Illness; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000191:economics / Q000209:etiology*; D008297:Male; D010343:Patient Admission / Q000706:statistics & numerical data; D011649:Pulmonary Alveolar Proteinosis / Q000150:complications* / Q000191:economics; D037721:Pulmonary Surfactant-Associated Protein C / Q000172:deficiency* / Q000191:economics
chemical_list: D037721:Pulmonary Surfactant-Associated Protein C